BKT-130

N/A

Report date: 2025/06/11 10:49:55
NME

Base Information

Drug NameBKT-130
Drug Alias Namechemokine antagonists (Biokine)BKT-120BKT-130
ClassificationSmall molecules
Mechanisms of ActionChemokine receptors antagonists
TargetsChemokine receptors
Therapy Area/IndicationsInflammationMacular DegenerationMultiple Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiokine Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiokine Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsInflammationMacular DegenerationMultiple Sclerosis
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A